Stewart Abbot
2015
In 2015, Stewart Abbot earned a total compensation of $1M as Chief Development Officer at Fate Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $20,806 |
---|---|
Option Awards | $567,182 |
Salary | $145,260 |
Stock Awards | $206,803 |
Other | $80,000 |
Total | $1,020,051 |
Abbot received $567.2K in option awards, accounting for 56% of the total pay in 2015.
Abbot also received $20.8K in non-equity incentive plan, $145.3K in salary, $206.8K in stock awards and $80K in other compensation.
Rankings
In 2015, Stewart Abbot's compensation ranked 7,847th out of 13,638 executives tracked by ExecPay. In other words, Abbot earned more than 42.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,847 | 43rd |
Manufacturing | 2,975 | 43rd |
Chemicals And Allied Products | 1,074 | 42nd |
Drugs | 867 | 43rd |
Biological Products, Except Diagnostic Substances | 145 | 43rd |
Abbot's colleagues
We found three more compensation records of executives who worked with Stewart Abbot at Fate Therapeutics in 2015.